However, the shift to precision oncology involves therapy based more on molecular profiles and the context of an individual ...
Adding stereotactic body radiation therapy (SBRT) or surgery directed at every known metastasis to first-line systemic ...
Dr. Jason Mouabbi revisits the patient's Grade 2 hyperglycemia at week 6, when fasting glucose reaches 212 mg/dL.
Dr. Jason Mouabbi returns to the patient case, noting improvement in the patient's osseous lesions and resolution of back ...
Dr. Jason Mouabbi discusses additional adverse events that require attention when managing patients with PIK3CA-mutated ...
Dr. Jason Mouabbi presents a 59-year-old postmenopausal woman with PIK3CA-mutated HR-positive/HER2-negative advanced breast ...
VIR-5500 and [²¹²Pb]PSV359 received FDA fast track designations for prostate cancer and solitary fibrous tumors, respectively ...
However, applying a conventional age-based testing threshold would have substantially reduced the number of patients identified. Restricting testing to patients diagnosed before age 50 would have ...
Dr. Jason Mouabbi discusses how available pathway-directed treatment approaches may be differentiated for patients with ...
Dr. Jason Mouabbi discusses strategies for assessing and managing the risk of treatment-related hyperglycemia before ...
Dr. Jason Mouabbi discusses the approach to managing treatment-related hyperglycemia while maintaining cancer treatment for ...
Mehta, MD, and participants discussed treatment selection for a patient with immune thrombocytopenia whose quality of life is impaired even as her platelet count recovers. Immune thrombocytopenia (ITP ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results